Experimental Treatment of Solar Chimney Power Plant—A Comprehensive Review

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Solar chimney power plants (SCPPs) are encouraging sustainable energy sources due to their low cost, abundance, low maintenance, and eco-friendliness. However, despite significant efforts to optimize SCPP design, their efficiency and power generation capabilities remain limited. Researchers have explored modifications in plant geometry and hybridization to improve efficiency. Despite extensive work in this area, commercialization of SCPPs has not yet been achieved. Most of the research is numerical and may differ from real-world practical use. The number of experimental studies is also relatively small. To facilitate commercialization, further investigation with practical and feasible dimensions is required. This comprehensive review paper aims to provide an in-depth analysis of experimental approaches and advancements in the field of SCPPs. The paper begins with an introduction, highlighting the background, significance, and objectives of the review. It provides an overview of the plants, discussing their principles and operation as innovative renewable energy systems. The historical development and evolution of solar chimneys are explored, shedding light on their progression over time. Case studies of operational hybrid SCPPs are examined to showcase real-world applications and performance. The paper also addresses environmental impacts and sustainability considerations associated with SCPPs. Furthermore, recommendations for future research and development in this field are provided to guide researchers and industry professionals. This study focuses on the possibility of commercialization of both standalone and hybrid SCPPs.

Related collections

Most cited references 163

Record: found
Abstract: found
Article: found

Is Open Access

Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015

AARON COHEN, Michael Brauer, Richard Burnett … (2017)

Summary Background Exposure to ambient air pollution increases morbidity and mortality, and is a leading contributor to global disease burden. We explored spatial and temporal trends in mortality and burden of disease attributable to ambient air pollution from 1990 to 2015 at global, regional, and country levels. Methods We estimated global population-weighted mean concentrations of particle mass with aerodynamic diameter less than 2·5 μm (PM2·5) and ozone at an approximate 11 km × 11 km resolution with satellite-based estimates, chemical transport models, and ground-level measurements. Using integrated exposure–response functions for each cause of death, we estimated the relative risk of mortality from ischaemic heart disease, cerebrovascular disease, chronic obstructive pulmonary disease, lung cancer, and lower respiratory infections from epidemiological studies using non-linear exposure–response functions spanning the global range of exposure. Findings Ambient PM2·5 was the fifth-ranking mortality risk factor in 2015. Exposure to PM2·5 caused 4·2 million (95% uncertainty interval [UI] 3·7 million to 4·8 million) deaths and 103·1 million (90·8 million 115·1 million) disability-adjusted life-years (DALYs) in 2015, representing 7·6% of total global deaths and 4·2% of global DALYs, 59% of these in east and south Asia. Deaths attributable to ambient PM2·5 increased from 3·5 million (95% UI 3·0 million to 4·0 million) in 1990 to 4·2 million (3·7 million to 4·8 million) in 2015. Exposure to ozone caused an additional 254 000 (95% UI 97 000–422 000) deaths and a loss of 4·1 million (1·6 million to 6·8 million) DALYs from chronic obstructive pulmonary disease in 2015. Interpretation Ambient air pollution contributed substantially to the global burden of disease in 2015, which increased over the past 25 years, due to population ageing, changes in non-communicable disease rates, and increasing air pollution in low-income and middle-income countries. Modest reductions in burden will occur in the most polluted countries unless PM2·5 values are decreased substantially, but there is potential for substantial health benefits from exposure reduction. Funding Bill & Melinda Gates Foundation and Health Effects Institute.